# US 2026/0167607 A1 · Compounds and compositions for treating conditions associated with lpa receptor activity

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0167607 A1
- Document ID: US20260167607A1
- Status: Published application
- Kind: A1
- Application number: 19/242,412
- Filed: 2025-06-18
- Published: 2026-06-18
- Earliest claimed: 2022-02-25
- Assignees: Lhotse Bio, Inc.
- Applicants: Lhotse Bio, Inc.
- Inventors: Wei HUANG; Hui LEI; Zhongmiao XU; Haizhen ZHANG; Qiong ZHANG
- Web page: https://patentgrep.com/patent/US20260167607A1

## CPC

- C07D 211/66: having a hetero atom as the second substituent in position 4
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 35/00: Antineoplastic agents
- A61P 37/00: Drugs for immunological or allergic disorders
- C07C 59/72: containing six-membered aromatic rings and other rings
- C07C 61/39: containing six-membered aromatic rings
- C07C 62/34: containing ether groups, [IMAGE cpc-sch-C07C-0958.gif] groups,[IMAGE cpc-sch-C07C-0959.gif] groups, or[IMAGE cpc-sch-C07C-0960.gif] groups
- C07C 229/18: the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
- C07C 229/28: the carbon skeleton being saturated and containing rings
- C07C 229/48: with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
- C07D 205/04: having no double bonds between ring members or between ring members and non-ring members
- C07D 213/65: attached in position 3 or 5
- C07D 309/14: Nitrogen atoms not forming part of a nitro radical
- C07D 317/50: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D 317/54: Radicals substituted by oxygen atoms
- C07D 317/58: Radicals substituted by nitrogen atoms (nitro radicals C07D317/52)
- C07D 401/12: linked by a chain containing hetero atoms as chain links
- C07D 405/12: linked by a chain containing hetero atoms as chain links
- C07D 407/12: linked by a chain containing hetero atoms as chain links
- C07C 2601/02: with a three-membered ring
- C07C 2601/04: with a four-membered ring
- C07C 2601/08: the ring being saturated
- C07C 2602/08: the other ring being five-membered, e.g. indane
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

The present disclosure provides LPA antagonists, as well as pharmaceutical compositions comprising the compounds disclosed herein. Also provided are methods for treating LPA-associated diseases, disorders, and conditions.

## Claims

### Claim at position 1

1-46. (canceled)

### Claim 47

A compound which is:
or a pharmaceutically acceptable salt thereof.

### Claim 48 (depends on 47)

A pharmaceutical composition comprising a compound of claim 47, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
